Congenital adrenal hyperplasia due to 21-hydroxylase deficiency

J Spec Pediatr Nurs. 2005 Jul-Sep;10(3):104-14. doi: 10.1111/j.1744-6155.2005.00022.x.

Abstract

Purpose: To provide an in-depth exploration of the complex and potentially life-threatening condition, congenital adrenal hyperplasia (CAH).

Conclusions: CAH affects adrenal gland function, resulting in abnormal steroidogenesis caused by a deficiency or complete lack of the enzyme 21-hydroxylase (accounting for 90% of CAH cases). Clinical manifestations include ambiguous genitalia in female newborns and life-threatening salt-wasting crisis in both male and female newborns.

Practice implications: Nurses should encourage and assist CAH patients and their parents in taking an active role in the management of their condition. Each stage of growth and development will bring new challenges and questions for patients and their parents.

Publication types

  • Review

MeSH terms

  • Adrenal Hyperplasia, Congenital* / diagnosis
  • Adrenal Hyperplasia, Congenital* / nursing
  • Adrenal Hyperplasia, Congenital* / physiopathology
  • Adrenal Hyperplasia, Congenital* / therapy
  • Disorders of Sex Development / embryology
  • Disorders of Sex Development / etiology
  • Female
  • Humans
  • Hydrocortisone / therapeutic use
  • Infant, Newborn
  • Male
  • Neonatal Screening
  • Pediatric Nursing
  • Steroid 21-Hydroxylase
  • Virilism / etiology

Substances

  • Steroid 21-Hydroxylase
  • Hydrocortisone